Product References
Galectin-3 and HBME-1 improve the accuracy of core biopsy in indeterminate thyroid nodules.
Endocrine
Trimboli P,Guidobaldi L,Amendola S,Nasrollah N,Romanelli F,Attanasio D,Ramacciato G,Saggiorato E,Valabrega S,Crescenzi A
MA5-12220 was used in immunohistochemistry - paraffin section to investigate using additional markers for core needle biopsy of thyroid nodules.
Fri Apr 01 00:00:00 EDT 2016
CD56, HBME-1 and cytokeratin 19 expressions in papillary thyroid carcinoma and nodular thyroid lesions.
Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences
Erdogan-Durmus S,Ozcan D,Yarikkaya E,Kurt A,Arslan A
MA512220 was used in immunohistochemistry - paraffin section to assess the use of CD56, HBME-1, cytokeratin 19 expression in papillary thyroid carcinoma and thyroid nodular lesions for differential diagnosis
Wed Mar 16 00:00:00 EDT 2022
Removal of H2A.Z by INO80 promotes homologous recombination.
EMBO reports
Alatwi HE,Downs JA
MA5-12220 was used in immunohistochemistry - paraffin section to investigate H2A.Z removal from chromatin.
Sat Aug 01 00:00:00 EDT 2015
Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
International journal of clinical and experimental pathology
Ceyran AB,Şenol S,Şimşek BÇ,Sağıroğlu J,Aydın A
MA5-12220 was used in immunohistochemistry - paraffin section to discuss how to distinguish follicular variant of PTC from other follicular-patterned lesions of the thyroid.
Thu Mar 24 00:00:00 EDT 2016
Molecular features of follicular variant papillary carcinoma of thyroid: comparison of areas with or without classical nuclear features.
Endocrine pathology
Guney G,Tezel GG,Kosemehmetoglu K,Yilmaz E,Balci S,Ersoy R,Cakir B,Guler G
MA5-12220 was used in immunohistochemistry to study cases of follicular variant papilliary carcinoma of the thyroid with and without classical nuclear changes
Mon Sep 01 00:00:00 EDT 2014
CXC motif ligand 12 as a novel diagnostic marker for papillary thyroid carcinoma.
Head & neck
Chung SY,Park ES,Park SY,Song JY,Ryu HS
MA5-12220 was used in immunohistochemistry to study the diagnostic value of the immunohistochemical expression of CXCL12 in papilliary thyroid carcinoma
Tue Jul 01 00:00:00 EDT 2014
Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
Pathology, research and practice
Abd-El Raouf SM,Ibrahim TR
MA5-12220 was used in immunohistochemistry - paraffin section to study the expression of galectin-3 and HMBE-1 in benign and malignant thyroid tissues in patients
Mon Dec 01 00:00:00 EST 2014
The use of core needle biopsy as first-line in diagnosis of thyroid nodules reduces false negative and inconclusive data reported by fine-needle aspiration.
World journal of surgical oncology
Trimboli P,Nasrollah N,Guidobaldi L,Taccogna S,Cicciarella Modica DD,Amendola S,Romanelli F,Lenzi A,Nigri G,Centanni M,Giovanella L,Valabrega S,Crescenzi A
MA5-12220 was used in immunohistochemistry to study the benefits of using core needle biopsy for the diagnosis of thyroid nodules as compared to using fine needle aspiration
Mon Mar 24 00:00:00 EDT 2014
Thin core biopsy should help to discriminate thyroid nodules cytologically classified as indeterminate. A new sampling technique.
Endocrine
Nasrollah N,Trimboli P,Guidobaldi L,Cicciarella Modica DD,Ventura C,Ramacciato G,Taccogna S,Romanelli F,Valabrega S,Crescenzi A
MA5-12220 was used in immunohistochemistry to study the ability to discriminate cytologically indeterminate thyroid nodules using thin core biopsies
Sat Jun 01 00:00:00 EDT 2013
Expression of cytokeratin 19, HBME-1 and galectin-3 in neoplastic and nonneoplastic thyroid lesions.
Polish journal of pathology : official journal of the Polish Society of Pathologists
Mataraci EA,Ozgüven BY,Kabukçuoglu F
MA5-12220 was used in immunohistochemistry to study the value of the immunohistochemical expression of CK-19, HBME-1 and galectin-3 for distinguishing benign and malignant lesions of the thyroid
Thu Mar 01 00:00:00 EST 2012
Primary malignant deciduoid peritoneal mesothelioma: a report of the cytohistological and immunohistochemical appearances.
Diagnostic cytopathology
Ustun H,Astarci HM,Sungu N,Ozdemir A,Ekinci C
MA5-12220 was used in immunohistochemistry to investigate deciduoid features of malignant mesothelioma by histomorphological and immunohistochemical evaluation
Wed Jun 01 00:00:00 EDT 2011
The urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells.
American journal of respiratory cell and molecular biology
Tucker TA,Dean C,Komissarov AA,Koenig K,Mazar AP,Pendurthi U,Allen T,Idell S
MA5-12220 was used in immunohistochemistry to investigate the role of urokinase receptor in the pathogenesis of malignant pleural mesothelioma
Tue Jun 01 00:00:00 EDT 2010
Universal markers of thyroid malignancies: galectin-3, HBME-1, and cytokeratin-19.
Endocrine pathology
Barut F,Onak Kandemir N,Bektas S,Bahadir B,Keser S,Ozdamar SO
MA5-12220 was used in immunohistochemistry to detect malignancies using immunohistochemical markers
Tue Jun 01 00:00:00 EDT 2010
Biphasic malignant mesothelioma cases with osseous differentiation and long survival: a review of the literature.
Lung cancer (Amsterdam, Netherlands)
Demirag F,Unsal E,Tastepe I
MA5-12220 was used in immunohistochemistry to report two clinical cases of biphasic malignant mesothelioma with osseous differentiation
Wed Aug 01 00:00:00 EDT 2007
Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis.
BMC cancer
Martarelli D,Catalano A,Procopio A,Orecchia S,Libener R,Santoni G
MA5-12220 was used in Immunohistochemistry to mimic the progression of human malignant mesothelioma.
Wed May 17 00:00:00 EDT 2006